Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Aldosterone
(D10528)		[1] Aldosterone[1] Aldosterone (D10528) 💬 [1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[3] 57, 75, 222 💬
2Aldosterone Antagonists
(D10528)		[1] Aldosterone[1] Aldosterone (D10528) 💬 [1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[1] 57 💬
3Diagnostic Test: Adrenal aldosterone synthase (CYP11B2) staining
(D10528)		[1] Aldosterone[1] Aldosterone (D10528) 💬 [1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[1] 75 💬
4Renin-angiotensin-aldosterone system inhibitors (RASI)
(D10528)		[1] Aldosterone[1] Aldosterone (D10528) 💬 [1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[1] 222 💬
5Symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
(D10528)		[3] Aldosterone,
Angiotensin II,
Calcium		[4] Angiotensin II ,
Angiotensin II ,
Aldosterone (D10528),
Angiotensin II acetate 💬 		[3] AGTR1,
AGTR2,
NR3C2 💬 		[18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 222 💬